Assoc. Prof. Dr. CEVPER ERSÖZ

Urology

MEDİPOL Acıbadem District Hospital

Make an Appointment

Birthplace

BURSA

Languages

ENGLISH

Medical Areas of Interest

Urological Cancers
Kidney Cancer
Prostate Cancer
Bladder Cancer
Testicular Cancer

Highlights

Assoc. Prof. Cevper Ersöz, MD was born in Bursa in 1981. He completed his pre-university education in Balıkesir. Having completed his medical education at Istanbul Faculty of Medicine in 2006, Dr. Ersöz received the title of Urology Specialist after completing his urology residency at Bezmialem Vakıf University Faculty of Medicine in 2012.

During his residency training, he spent time at the Department of Urology of the University of Michigan, United States, in 2011, gaining clinical experience in advanced laparoscopy, robotic surgery and endourology.

Following the completion of his compulsory service as a Urology Specialist at Şırnak İdil State Hospital in 2014, he worked as a Urology Specialist at Giresun Dr. A. İlhan Özdemir State Hospital between 2014 and 2015. In 2015, he began working as a faculty member at the Department of Urology of Bezmialem Vakıf University, and in 2021 he successfully passed the European Board of Urology Qualification Examination and received the title of FEBU (Fellow of the European Board of Urology). He received the title of Associate Professor at the same institution in 2023 and continued his academic and clinical activities there until 2024. He currently continues his clinical and academic work at Medipol Acıbadem Regional Hospital and Medipol University. In 2025, he was at Westmoreland Street Hospital, UCL, London as an observer in advanced urological oncology robotic surgery.

Starting from his residency years and continuing into the post-specialization period, he has been particularly interested in urological oncology and endoscopic surgery. He has performed more than 10,000 procedures with laparoscopic, robotic and endoscopic surgical techniques. He has advanced clinical and surgical experience particularly in his areas of interest: robotic and open surgery in the treatment of prostate cancer; robotic, laparoscopic and open surgery in the surgical treatment of kidney and ureteral tumors; endoscopic surgery for the early stages of bladder cancer and radical surgery for its advanced stages; and the treatment of all stages of testicular cancer. Endourological surgeries for conditions such as prostate diseases and kidney stones are also among his areas of interest.

The work of Assoc. Prof. Cevper Ersöz, who has more than 40 scientific articles in national and international peer-reviewed journals and more than 10 book chapters and reviews, has received more than 1600 citations in the international literature.

Assoc. Prof. Cevper Ersöz continues his clinical and educational activities while developing himself nationally and internationally. His priority stands out as the success of his patients' treatment and patient satisfaction.

Experiences

2015 - 2024

Bezmialem Vakıf University, Department of Urology

2014 - 2015

Giresun Dr. A. İlhan Özdemir State Hospital, Giresun

2012 - 2014

İdil State Hospital, İdil, Şırnak

2011 - 2011

University of Michigan, Department of Urology, Ann Arbor, MI, USA

2010 - 2012

Bezmialem University, Department of Urology

2007 - 2010

Bezmialem Valide Sultan Vakıf Gureba Training and Research Hospital, Urology Clinic

2006 - 2007

Istanbul University, Istanbul Faculty of Medicine, Department of Anatomy

Educations

2012

Istanbul Bezmialem Vakıf University, Urology

2006

Istanbul University, Faculty of Medicine

Publications

7.1. Articles published in international peer-reviewed journals

7.1.1. Curcumin prevents oxidative renal damage induced by acetaminophen in rats. Cekmen M, Ilbey YO, Ozbek E, Simsek A, Somay A, Ersoz C. Food Chem Toxicol; 47(7):1480-4 (2009).

7.1.2. Impact of percutaneous renal access technique on outcomes of percutaneous nephrolithotomy. Tepeler A, Armağan A, Akman T, Polat EC, Ersöz C, Topaktaş R, Erdem MR, Onol SY. J Endourol; 26(7):828-33 (2012).

7.1.3. Re: Xu Y: Doppler Ultrasound-guided Percutaneous Nephrolithotomy With Two-step Tract Dilation for Management of Complex Renal Stones. Tepeler A, Akman T, Ersoz C, Armagan A. Urology; 80(3):745-6 (2012).

7.1.4. The role of microperc in the treatment of symptomatic lower pole renal calculi. Tepeler A, Armagan A, Sancaktutar AA, Silay MS, Penbegul N, Akman T, Hatipoglu NK, Ersoz C, Erdem MR, Akcay M. J Endourol; 27(1):13-8 (2013).

7.1.5. Is the percutaneous nephrolithotomy procedure complicated in patients with anterior caliceal stones? Tepeler A, Bozkurt OF, Resorlu B, Silay MS, Ozyuvali E, Ersoz C, Akcay M, Akman T, Armagan A, Unsal A. Urol Int; 90(4):389-93 (2013).

7.1.6. Circumcision during the phallic period: does it affect the psychosexual functions in adulthood? Armagan A, Silay MS, Karatag T, Akman T, Tepeler A, Ersoz C, Akcay M. Andrologia Feb 5. Doi 10.1111/and.12071 (2013).

7.1.7. Micropercutaneous nephrolithotomy in the treatment of moderate-size renal calculi.

Armagan A, Tepeler A, Silay MS, Ersoz C, Akcay M, Akman T, Erdem MR, Onol SY.

J Endourol; 27(2):177-81 (2013).

7.1.8. Comparison of flexible and rigid cystoscopy-assisted ureteral catheter insertion before percutaneous nephrolithotomy: a prospective randomized trial. Tepeler A, Silay MS, Akman T, Akcay M, Ersoz C, Kardas S, Erdem MR, Armagan A, Onol SY. J Endourol; 27(6): 722-6 (2013).

7.1.9. Comparison of intrarenal pelvic pressure during micro-percutaneous nephrolithotomy and conventional percutaneous nephrolithotomy. Tepeler A, Akman T, Silay MS, Akcay M, Ersoz C, Kalkan S, Armagan A, Sarica K. Urolithiasis; Feb 13. (2014).

7.1.10. Our experience in chordee without hypospadias: results of 102 cases. Polat EC, Erdem MR, Topaktas R, Ersoz C, Onol SY. Urol J; Sep 6;11(4):1783-7 (2014)

7.1.11. Iatrogenic Rectal Injury During Radical Prostatectomy: Is Colostomy Inevitable End? Topaktaş R, Erdem MR, Polat EC, Ersöz C, Önol ŞY. J Clin Anal Med ; DOI: 10.4328/JCAM.3419.(2015)

7.1.12. A Modified Antegrade Stenting Technique for Laparoscopic Pyeloplasty in Infants and Children. Kalkan S, Ersöz C, Armagan A, Taşçı Aİ, Silay MS. Urol Int. 2016;96(2):183-7. (2016)

7.1.13. Comparison of Scoring Systems in Predicting Success of Percutaneous Nephrolithotomy. Akçay M, Tosun M, Gevher F, Kalkan S, Ersöz C, Kayalı Y, Tepeler A. Balkan Med J. Jan 1;36(1):32-36. (2019)

7.1.14. Mesh related vesico-peritoneal fistula presenting with urinary ascites: A case report. Ilktac A, Ersoz C, Dogan B, Kalkan S. Urol Case Rep. Dec 4;23:39-40.(2018)

7.1.15. The relationship of neutrophil to lymphocyte ratio with testicular cancer. Ilktac A, Dogan B, Ersoz C, Akcay M, Akbulut H. Int Braz J Urol. Jan-Feb;46(1):101-107 (2020)

7.1.16. Efficacy of varicocelectomy in primary infertile patients with isolated teratozoospermia. A retrospective analysis. Ilktac A, Hamidli S, Ersoz C, Dogan B, Akcay M. Andrologia. 2020 Dec;52(11):e13875

7.1.17. Association of intrinsic sphincter deficiency with urine flow acceleration measurement. Karasu AFG, Aydın S, Kalkan S, Ersoz C. Low Urin Tract Symptoms. 2021 Jan;13(1):154-159.

7.1.18. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? Demir T, Aliyev A, Beşiroğlu M, Araz M, Köstek O, Sakin A, Shbair ATM, Çoban G, Ersöz C, Şeker M, Türk HM. Curr Probl Cancer. 2021 Feb;45(1):100619

7.1.19. The optimal settings of holmium YAG laser in treatment of pediatric urolithiasis. Ersoz C, Ilktac A, Dogan B, Kalkan S, Danacioglu YO, Silay MS. Lasers Med Sci. 2021 Jan 21. doi: 10.1007/s10103-021-03251-y. Online ahead of print.

7.1.20. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. COVIDSurg Collaborative; GlobalSurg Collaborative. Anaesthesia. 2021 Jun;76(6):748-758.

7.1.21. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort. Danacioglu YO, Keser F, Ersoz C, Polat S, Avci AE, Kalkan S, Silay MS. J Pediatr Urol. 2021 Feb 23:S1477-5131(21)00102-9.

7.1.22. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. COVIDSurg Collaborative, GlobalSurg Collaborative. Br J Surg. 2021 Mar 24:znab101. doi: 10.1093/bjs/znab101. Online ahead of print.

7.1.23. Primitive Neuroectodermal Tumor of the Testis. Demir T, Aliyev A, Seker M, Ersoz C, Coban G, Turk HM. J Coll Physicians Surg Pak. 2021 Nov;31(11):1362-1365. doi: 10.29271/jcpsp.2021.11.1362. PMID: 34689500.

7.1.24. Ersoz C, İlktac A, Kalkan S, et al. Systematic versus cognitive targeted biopsy: evaluation of parameters related to clinically significant prostate cancer and comparison of detection rates. New J Urol. 2022;17(3):187-195. https://doi.org/10.33719/yud.2022;17-3-1143471

7.1.25. Kayalı Y, Balbay MD, İlktaç A, Ersöz C, Toprak H, Tarım K, Eden AB, Akçay M, Doğan B. PSA change after antibiotic treatment should not affect decision making on performing a prostate biopsy. Turk J Med Sci. 2023 Feb;53(1):183-192. doi: 10.55730/1300-0144.5571. Epub 2023 Feb 22. PMID: 36945961; PMCID: PMC10388076.

7.1.26. Çoban G, Yıldız P, Şahin N, Ersöz C, Toprak A, Ünver N, Elagöz Ş. CD47 expression in urothelial carcinoma and its correlation with histopathological findings. Indian J Cancer. 2023 Oct 1;60(4):458-463. doi: 10.4103/ijc.ijc_644_21. Epub 2023 Nov 30. PMID: 38078465.

7.1.27. Ilktac A, Dogan B, Ersoz C, Coban G, Kalkan S. Characteristics of the Patients Aged Less than 40 Years Operated for a Renal Mass. J Kidney Cancer VHL. 2023 Dec 21;10(4):20-27. doi: 10.15586/jkcvhl.v10i4.287. PMID: 38145031; PMCID: PMC10748823.

7.1.28. Beyaztas H, Ersoz C, Ozkan BN, Olgun I, Polat HS, Dastan AI, Cetinkaya E, Guler EM. The role of oxidative stress and inflammation biomarkers in pre- and postoperative monitoring of prostate cancer patients. Free Radic Res. 2024 Feb;58(2):98-106. doi: 10.1080/10715762.2024.2320381. Epub 2024 Feb 23. PMID: 38373238.